How should I interpret a 36-year-old woman's laboratory results showing normal red blood cell count (RBC), low hemoglobin (Hb), low hematocrit (Hct), microcytosis (low mean corpuscular volume, MCV), low mean corpuscular hemoglobin (MCH), low mean corpuscular hemoglobin concentration (MCHC), elevated total iron‑binding capacity (TIBC), elevated unsaturated iron‑binding capacity (UIBC), low serum iron (Fe), elevated transferrin (Tf), and low ferritin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation: Severe Absolute Iron Deficiency with Early Microcytic Anemia

This 36-year-old woman has severe absolute iron deficiency with early microcytic anemia, confirmed by a ferritin of 8 ng/mL (far below the diagnostic threshold of <15 ng/mL, which has 99% specificity for iron deficiency) and a transferrin saturation of 4.4% (calculated as [22 ÷ 496] × 100), well below the critical threshold of 16%. 1

Laboratory Pattern Analysis

Iron Studies:

  • Ferritin 8 ng/mL: Definitively confirms depleted iron stores; this value is approximately 1 μg/L of serum ferritin equals 10 mg of stored iron, indicating near-complete depletion of body iron reserves 2, 1
  • Transferrin saturation 4.4%: Severely reduced iron availability for erythropoiesis; values <16% confirm iron deficiency even when other parameters are equivocal 2, 1
  • Elevated TIBC (496 mg/dL) and UIBC (474 mg/dL): The body is attempting to capture more circulating iron by increasing transferrin production, a compensatory response to depleted stores 2, 3
  • Low serum iron (22 μg/dL): Reflects insufficient iron in circulation for immediate hemoglobin synthesis 2, 3

Red Blood Cell Parameters:

  • Hemoglobin 11.4 g/dL: Below the normal threshold of 12 g/dL for nonpregnant women, confirming anemia 4
  • MCV 79 fL, MCH 24.2 pg, MCHC 30.5 g/dL: All reduced, indicating microcytic hypochromic anemia characteristic of iron-restricted erythropoiesis 2, 3, 5
  • RBC 4.72 million/μL: Relatively preserved count despite anemia, reflecting the body's attempt to maintain oxygen-carrying capacity by producing more (albeit smaller and paler) red cells 5

This pattern represents Stage 2 iron deficiency where MCV and MCH have declined, hemoglobin is subnormal but above 9 g/dL, and transferrin saturation is far below 16%. 5

Immediate Management Protocol

1. Initiate Oral Iron Supplementation Immediately:

  • Start ferrous sulfate 65 mg elemental iron daily, or 60 mg every other day (alternate-day dosing improves absorption by 30-50% and reduces gastrointestinal side effects) 1
  • Take on an empty stomach for optimal absorption, or with meals if gastrointestinal symptoms develop 1
  • Expected response: hemoglobin should rise by ≥10 g/L within 2 weeks of starting therapy 1

2. Investigate the Source of Iron Loss:

For a 36-year-old premenopausal woman, the diagnostic algorithm should proceed as follows:

  • Assess menstrual history: Heavy or prolonged menstrual bleeding (menometrorrhagia) is the most common cause of iron deficiency in this population 6, 4
  • Screen for celiac disease: Obtain tissue transglutaminase IgA antibodies; celiac disease accounts for 3-5% of iron deficiency cases and causes treatment failure if missed 1
  • Test for Helicobacter pylori: Use stool antigen or urea breath test; the organism impairs iron absorption 1

Reserve bidirectional endoscopy for:

  • Age ≥50 years (higher malignancy risk)
  • Gastrointestinal symptoms (abdominal pain, altered bowel habits, visible blood in stool)
  • Positive celiac or H. pylori testing requiring confirmation
  • Failure to respond to adequate oral iron after 8-10 weeks
  • Strong family history of colorectal cancer 1

In young, asymptomatic premenopausal women with heavy menses and no gastrointestinal symptoms, empiric oral iron supplementation without immediate endoscopy is appropriate. 1

3. Consider Intravenous Iron if:

  • Oral iron intolerance develops (constipation, nausea, diarrhea)
  • Malabsorption is documented (celiac disease, inflammatory bowel disease)
  • Ongoing blood loss exceeds oral replacement capacity
  • Pregnancy in second/third trimester 1

Follow-Up and Monitoring

  • Repeat CBC and ferritin at 8-10 weeks to assess response to treatment 1
  • Target ferritin >100 ng/mL to fully replenish iron stores and prevent recurrence 1
  • For recurrent low ferritin (common in menstruating females), schedule ferritin screening every 6-12 months 1
  • Do not continue daily iron supplementation once ferritin normalizes, as this is potentially harmful 1

Critical Pitfalls to Avoid

  • Do not assume normal hemoglobin excludes significant iron deficiency: This patient's hemoglobin of 11.4 g/dL is only mildly reduced, yet her ferritin of 8 ng/mL indicates severe depletion of iron stores 1, 5
  • Do not overlook celiac disease screening: Its 3-5% prevalence in iron deficiency cases can lead to treatment failure if not identified 1
  • Do not perform extensive gastrointestinal investigation in young, asymptomatic premenopausal women with heavy menses: The yield is extremely low (0-6.5%) unless red flags are present 1
  • Do not misinterpret this as anemia of chronic disease: The elevated TIBC (496 mg/dL) definitively excludes anemia of chronic disease, which presents with low or normal TIBC 3, 7

References

Guideline

Normal Values for Ferritin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of microcytosis.

American family physician, 2010

Related Questions

What is the diagnosis and recommended treatment for a 43‑year‑old woman with microcytic anemia (hemoglobin 8.4 g/dL, mean corpuscular volume 74 fL), leukocytosis (white blood cell count 13.5 ×10⁹/L, neutrophils 8.5 ×10⁹/L), pre‑diabetes (hemoglobin A1c 6.1 %), hypercholesterolemia (total cholesterol 238 mg/dL, low‑density lipoprotein 116 mg/dL) and hypertriglyceridemia (triglycerides 407 mg/dL)?
In a 40‑year‑old woman with hemoglobin 10.5 g/dL, hematocrit 34.1 %, mean corpuscular volume 72.1 fL, mean corpuscular hemoglobin 22.2 pg, mean corpuscular hemoglobin concentration 30.8 g/dL, and red cell distribution width 17.2 %, what is the most likely diagnosis and the appropriate initial work‑up and treatment?
A 25‑year‑old woman with iron‑deficiency anemia (low serum iron, low ferritin, high total iron‑binding capacity, microcytosis) started oral iron and now shows a modest rise in hemoglobin; how long should supplementation continue, when should repeat iron studies be obtained, what counseling should be provided, and how should I evaluate for an occult source of blood loss?
What is the management plan for a patient with anisocytosis, microcytosis, and poikilocytosis?
What is the diagnosis and treatment for a 32-year-old pregnant woman at 13 weeks gestation with anorexia (lack of appetite), skin hyperpigmentation (darkening of the skin), diarrhea, nausea, low hematocrit (34%), anemia (hemoglobin 10.4), and microcytic hypochromic anemia (mean corpuscular hemoglobin 40, mean corpuscular volume 105)?
How does mast‑cell activation syndrome contribute to the vasodilation and blood pooling that cause POTS, and why do antihistamines improve the tachycardia?
I have had a dry cough for one month; what evaluation and management is recommended?
What is the workup for a low serum lactate dehydrogenase (LDH) level and what are the differential diagnoses?
53-year-old female with a 5-day history of productive purulent cough, low-grade fever, pleuritic chest pain, shortness of breath on exertion, tachypnea, normal heart rate, normotension, adequate oxygen saturation, increased left tactile fremitus, dullness to percussion, crackles and egophony over the left base, no past medical history, up-to-date childhood vaccines but no pneumococcal or COVID-19 vaccination—what is the most likely diagnosis and appropriate outpatient management?
In an adult patient on duloxetine (Cybalta) 30‑60 mg daily for 4‑6 weeks with inadequate symptom control or intolerable side effects, how should the regimen be adjusted or changed?
Does ginger have antiplatelet (blood‑thinning) effects?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.